Search by Drug Name or NDC
NDC 72865-0167-60 Abacavir 300 mg/1 Details
Abacavir 300 mg/1
Abacavir is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XLCare Pharmaceuticals Inc.. The primary component is ABACAVIR SULFATE.
MedlinePlus Drug Summary
Abacavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Abacavir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood. Although abacavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
Related Packages: 72865-0167-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Abacavir
Product Information
| NDC | 72865-0167 |
|---|---|
| Product ID | 72865-167_f26efe20-afb4-390a-e053-2a95a90ae396 |
| Associated GPIs | 12105005100320 |
| GCN Sequence Number | 040964 |
| GCN Sequence Number Description | abacavir sulfate TABLET 300 MG ORAL |
| HIC3 | W5J |
| HIC3 Description | ANTIVIRALS, HIV-SPECIFIC, NUCLEOSIDE ANALOG, RTI |
| GCN | 94668 |
| HICL Sequence Number | 018857 |
| HICL Sequence Number Description | ABACAVIR SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Abacavir |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Abacavir |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | ABACAVIR SULFATE |
| Labeler Name | XLCare Pharmaceuticals Inc. |
| Pharmaceutical Class | Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091560 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72865-0167-60 (72865016760)
| NDC Package Code | 72865-167-60 |
|---|---|
| Billing NDC | 72865016760 |
| Package | 60 TABLET in 1 BOTTLE (72865-167-60) |
| Marketing Start Date | 2021-05-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |